Laurion Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $214K | Sell |
886
-99
| -10% | -$23.9K | ﹤0.01% | 218 |
|
|
2025
Q1 | $240K | Buy |
+985
| New | +$240K | 0.01% | 136 |
|
|
2024
Q4 | – | Sell |
-959
| Closed | -$321K | – | 168 |
|
|
2024
Q3 | $321K | Buy |
+959
| New | +$321K | ﹤0.01% | 140 |
|
|
2020
Q4 | – | Sell |
-440
| Closed | -$227K | – | 443 |
|
|
2020
Q3 | $227K | Buy |
+440
| New | +$227K | ﹤0.01% | 544 |
|
|
2019
Q4 | – | Sell |
-12,643
| Closed | -$4.21M | – | 518 |
|
|
2019
Q3 | $4.21M | Buy |
+12,643
| New | +$4.21M | 0.03% | 95 |
|
|
2019
Q2 | – | Sell |
-1,100
| Closed | -$336K | – | 577 |
|
|
2019
Q1 | $336K | Buy |
+1,100
| New | +$336K | ﹤0.01% | 443 |
|
|
2017
Q3 | – | Sell |
-6,572
| Closed | -$1.49M | – | 1077 |
|
|
2017
Q2 | $1.49M | Sell |
6,572
-16,828
| -72% | -$3.81M | 0.01% | 481 |
|
|
2017
Q1 | $4.67M | Buy |
+23,400
| New | +$4.67M | 0.04% | 132 |
|